Medfinder
Back to blog

Updated: January 27, 2026

Rabies Immune Globulin Drug Interactions: What to Avoid and What to Tell Your Doctor

Author

Peter Daggett

Peter Daggett

Two medication bottles with caution symbol showing rabies immune globulin drug interactions

Does rabies immune globulin interact with other drugs or vaccines? Learn which medications and vaccines interact with HRIG, including live vaccines, immunosuppressants, and more.

Rabies immune globulin (HRIG) is a passive immunization product that can interact with certain medications and vaccines. Most of these interactions involve the timing of live vaccines — but there are also important interactions with specific biologics and immunosuppressants. Here is what you need to know before receiving HRIG.

Most Critical Interaction: Live Vaccines

The most clinically important drug interaction with HRIG involves live attenuated vaccines. Because HRIG contains a high concentration of human antibodies, these passive antibodies can interfere with the immune response to live vaccines — neutralizing the vaccine virus before your body can mount an immune response.

Required waiting periods after receiving HRIG:

Measles vaccine: Wait at least 4 months (longer than other live vaccines, due to the measles vaccine's particular sensitivity to passive antibody interference)

MMR (measles, mumps, rubella): Wait at least 4 months

Varicella (chickenpox) vaccine: Wait at least 3 months

Other live vaccines (polio, rotavirus, typhoid, yellow fever): Wait at least 3 months

Important exception: This delay does NOT apply to the rabies vaccine itself. HRIG is specifically designed to be administered alongside the rabies vaccine (an inactivated vaccine) without suppressing the rabies vaccine's immune response — when given at the correct dose of 20 IU/kg.

Interaction with Immunosuppressive Drugs and CAR-T Cell Therapies

HRIG and certain immunosuppressive agents have a pharmacodynamic interaction — the combined use increases the risk of infection and reduces overall immune effectiveness. This is particularly important with:

CAR-T cell therapies (axicabtagene ciloleucel / Yescarta, brexucabtagene autoleucel / Tecartus, ciltacabtagene autoleucel / Carvykti, idecabtagene vicleucel / Abecma, lisocabtagene maraleucel / Breyanzi, tisagenlecleucel / Kymriah)

Both HRIG and CAR-T therapies affect the immune system in different ways; combining them increases immunosuppressive effects and infection risk. If a patient receiving CAR-T therapy has a rabies exposure, consult with the oncology team about timing and approach for PEP.

Interaction with Efgartigimod (Vyvgart)

Efgartigimod alfa (Vyvgart) and efgartigimod/hyaluronidase (Vyvgart Hytrulo) are FcRn receptor antagonists used to treat generalized myasthenia gravis. These drugs work by blocking the neonatal Fc receptor (FcRn) — the same receptor that recycles IgG antibodies (including HRIG) and keeps them in circulation.

When efgartigimod is given alongside HRIG, it can reduce the half-life and effectiveness of HRIG by preventing the normal recycling of IgG antibodies. The result: HRIG may be cleared from your system faster than normal, potentially reducing its protective window.

Severity: Moderate — Use Caution/Monitor. If long-term efgartigimod use is essential, consider temporarily discontinuing it and using an alternative therapy during the PEP window. Consult with the prescribing neurologist.

Interaction with BCG Vaccine (Live)

High doses of immune globulin (including HRIG) may impair the immune response to BCG vaccine (Bacillus Calmette-Guérin, a live attenuated tuberculosis vaccine used in some countries and for bladder cancer treatment). This falls into the same category as other live vaccine interactions.

HRIG and Immunocompromised Patients

Patients on immunosuppressive drugs — corticosteroids, biologics (e.g., adalimumab, infliximab, etanercept), chemotherapy, or organ transplant medications — may have a reduced response to the rabies vaccine component of PEP (not to HRIG itself). ACIP recommends that immunocompromised patients receive:

5 doses of rabies vaccine (Days 0, 3, 7, 14, and 28) rather than the standard 4 doses

Rabies virus neutralizing antibody (RVNA) titer testing 7-14 days after the final vaccine dose to confirm protective immunity (≥0.5 IU/mL)

What to Tell Your Doctor Before Receiving HRIG

Before receiving HRIG, inform your healthcare provider about:

Any history of allergic reactions to blood products, immune globulins, or plasma-derived products

Known IgA deficiency (associated with higher risk of severe hypersensitivity reactions)

Current use of any immunosuppressive medications, biologics, or CAR-T therapy

Any recent live vaccines (within the past 2-4 weeks) — particularly if you are due for MMR, varicella, or yellow fever boosters

Pregnancy or breastfeeding

Upcoming travel that would require additional live vaccines

Does HRIG Interact With Birth Control or Hormones?

There is no documented significant interaction between HRIG and hormonal contraceptives or hormone replacement therapy. However, as with any biologic, inform your provider of all medications you take, including birth control pills or patches.

Also read: Rabies Immune Globulin Side Effects: What to Expect and When to Call Your Doctor for a full list of adverse reactions.

Need to find a facility near you that can administer HRIG? medfinder can help.

Frequently Asked Questions

Yes, but immunocompromised patients may have a reduced vaccine response. ACIP recommends 5 doses of rabies vaccine (Days 0, 3, 7, 14, and 28) for immunocompromised patients, plus rabies antibody titer testing 7-14 days after the final dose to confirm protective immunity. HRIG dosing itself does not change for immunocompromised patients.

Wait at least 4 months after receiving HRIG before getting the MMR vaccine (measles, mumps, rubella). The passive antibodies in HRIG can interfere with the live measles virus in the vaccine, preventing your immune system from building a protective response. Other live vaccines (varicella, yellow fever, typhoid, polio) require a 3-month wait.

There is no major documented interaction between HRIG and anticoagulants (blood thinners) like warfarin or direct oral anticoagulants. However, HRIG does carry a rare risk of thromboembolism (blood clots) as a biologic side effect. Patients on anticoagulants should inform their provider, who will monitor for any unusual symptoms after HRIG administration.

HRIG itself can generally be administered regardless of biologic therapy. However, patients on TNF inhibitors (adalimumab, infliximab, etanercept) or other immunosuppressants may have a blunted response to the rabies vaccine component of PEP. ACIP recommends an additional 5th vaccine dose on Day 28 and antibody titer testing for these patients.

Potentially, yes — the interaction goes both ways. Efgartigimod blocks the FcRn receptor that recycles IgG antibodies, which means HRIG may be cleared from your system faster than normal when on efgartigimod, potentially shortening its protective window. If you are on efgartigimod and need HRIG, consult with your neurologist about whether to temporarily suspend efgartigimod during the PEP window.

Medfinder Editorial Standards

Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.

Read our editorial standards

Patients searching for Rabies Immune Globulin, Human also looked for:

Equine Rabies Immune Globulin (ERIG)Monoclonal antibody cocktails (TwinRab — docaravimab/miromavimab)RabAvert (purified chick embryo cell vaccine)Imovax (human diploid cell vaccine)

33,355 have already found their meds with Medfinder.

Start your search today.

33K+
5-star ratingTrusted by 33,355 Happy Patients
      What med are you looking for?
⊙  Find Your Meds
99% success rate
Fast turnaround time
Never call another pharmacy

Need this medication?